These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 19724043)

  • 61. The association between latrine use and trachoma: a secondary cohort analysis from a randomized clinical trial.
    Haile M; Tadesse Z; Gebreselassie S; Ayele B; Gebre T; Yu SN; Stoller NE; Gaynor BD; Porco TC; Emerson PM; Lietman TM; Keenan JD
    Am J Trop Med Hyg; 2013 Oct; 89(4):717-20. PubMed ID: 24002488
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mass treatment with single-dose azithromycin for trachoma.
    Solomon AW; Holland MJ; Alexander ND; Massae PA; Aguirre A; Natividad-Sancho A; Molina S; Safari S; Shao JF; Courtright P; Peeling RW; West SK; Bailey RL; Foster A; Mabey DC
    N Engl J Med; 2004 Nov; 351(19):1962-71. PubMed ID: 15525721
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Coverage of azithromycin mass treatment for trachoma elimination in Northwestern Ethiopia: a community based cross-sectional study.
    Tilahun Z; Fenta TG
    BMC Ophthalmol; 2018 Aug; 18(1):193. PubMed ID: 30081851
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of Mass Azithromycin Distributions on Childhood Growth in Niger: A Cluster-Randomized Trial.
    Arzika AM; Maliki R; Ali MM; Alio MK; Abdou A; Cotter SY; Varnado NE; Lebas E; Cook C; Oldenburg CE; O'Brien KS; Callahan EK; Bailey RL; West SK; Porco TC; Lietman TM; Keenan JD;
    JAMA Netw Open; 2021 Dec; 4(12):e2139351. PubMed ID: 34967883
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa.
    Last AR; Burr SE; Harding-Esch E; Cassama E; Nabicassa M; Roberts CH; Mabey DCW; Holland MJ; Bailey RL
    Parasit Vectors; 2017 Dec; 10(1):624. PubMed ID: 29282126
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Effect of Mass Azithromycin Distribution on Childhood Mortality: Beliefs and Estimates of Efficacy.
    See CW; O'Brien KS; Keenan JD; Stoller NE; Gaynor BD; Porco TC; Lietman TM
    Am J Trop Med Hyg; 2015 Nov; 93(5):1106-9. PubMed ID: 26392160
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control.
    West SK; Munoz BE; Mkocha H; Gaydos C; Quinn T
    Ophthalmic Epidemiol; 2015; 22(3):170-5. PubMed ID: 26158574
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study.
    West SK; Munoz B; Mkocha H; Holland MJ; Aguirre A; Solomon AW; Foster A; Bailey RL; Mabey DC
    Lancet; 2005 Oct; 366(9493):1296-300. PubMed ID: 16214600
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Stopping azithromycin mass drug administration for trachoma: A systematic review.
    Mahmud H; Landskroner E; Amza A; Aragie S; Godwin WW; de Hostos Barth A; O'Brien KS; Lietman TM; Oldenburg CE
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009491. PubMed ID: 34237074
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mass Azithromycin and Malaria Parasitemia in Niger: Results from a Community-Randomized Trial.
    O'Brien KS; Cotter SY; Amza A; Kadri B; Nassirou B; Stoller NE; Zhou Z; Cotter C; West SK; Bailey RL; Rosenthal PJ; Gaynor BD; Porco TC; Lietman TM
    Am J Trop Med Hyg; 2017 Sep; 97(3):696-701. PubMed ID: 28722569
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Annual Versus Biannual Mass Azithromycin Distribution and Malaria Parasitemia During the Peak Transmission Season Among Children in Niger.
    Oldenburg CE; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Keenan JD; Lietman TM; Gaynor BD
    Pediatr Infect Dis J; 2018 Jun; 37(6):506-510. PubMed ID: 29088030
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community.
    West ES; Munoz B; Mkocha H; Holland MJ; Aguirre A; Solomon AW; Bailey R; Foster A; Mabey D; West SK
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):83-7. PubMed ID: 15623758
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia.
    Stare D; Harding-Esch E; Munoz B; Bailey R; Mabey D; Holland M; Gaydos C; West S
    Ophthalmic Epidemiol; 2011 Feb; 18(1):20-9. PubMed ID: 21275593
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?
    West SK; Moncada J; Munoz B; Mkocha H; Storey P; Hardick J; Gaydos CA; Quinn TC; Schachter J
    J Infect Dis; 2014 Jul; 210(1):65-71. PubMed ID: 24446528
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR).
    Arzika AM; Abdou A; Maliki R; Beido N; Kadri B; Harouna AN; Galo AN; Alio MK; Lebas E; Oldenburg CE; O'Brien KS; Chen C; Zhong L; Zhou Z; Yan D; Hinterwirth A; Keenan JD; Porco TC; Lietman TM; Doan T;
    PLoS Med; 2024 May; 21(5):e1004386. PubMed ID: 38709718
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Does mass azithromycin distribution impact child growth and nutrition in Niger? A cluster-randomized trial.
    Amza A; Yu SN; Kadri B; Nassirou B; Stoller NE; Zhou Z; West SK; Bailey RL; Gaynor BD; Keenan JD; Porco TC; Lietman TM
    PLoS Negl Trop Dis; 2014 Sep; 8(9):e3128. PubMed ID: 25210836
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment coverage of mass administration of azithromycin among children aged 1-11 months in 21 districts of Kebbi state, Nigeria.
    Wamyil-Mshelia T; Madaki S; Isiyaku S; Shu'aibu J; Olobio NP; Aliero AA; Abdulsalam M; Taiwo J; McDickoh VJ
    Int Health; 2023 Dec; 15(Supplement_2):ii12-ii18. PubMed ID: 38048379
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Azithromycin distribution and childhood mortality in compliance-related subgroups in Niger: complier average causal effect and spillovers in a cluster-randomized, placebo-controlled trial.
    O'Brien KS; Arzika AM; Maliki R; Amza A; Manzo F; Mankara AK; Lebas E; Cook C; Oldenburg CE; Porco TC; Arnold BF; Bertozzi S; Keenan JD; Lietman TM
    Int J Epidemiol; 2022 Dec; 51(6):1775-1784. PubMed ID: 34508582
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nasopharyngeal Pneumococcal Serotypes Before and After Mass Azithromycin Distributions for Trachoma.
    Keenan JD; Sahlu I; McGee L; Cevallos V; Vidal JE; Chochua S; Hawkins P; Gebre T; Tadesse Z; Emerson PM; Gaynor BD; Lietman TM; Klugman KP
    J Pediatric Infect Dis Soc; 2016 Jun; 5(2):222-6. PubMed ID: 27199475
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger.
    O'Brien KS; Arzika AM; Maliki R; Manzo F; Mamkara AK; Lebas E; Cook C; Bailey RL; West SK; Oldenburg CE; Porco TC; Arnold B; Keenan JD; Lietman TM;
    PLoS Med; 2020 Sep; 17(9):e1003285. PubMed ID: 32931496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.